erythropoietin therapy
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation.
2
Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
7
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion.
3
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
10
Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients.
13
Prediction of response to recombinant human erythropoietin in the anemia of cancer
42
The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply.
8
Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.
11
Hormonal therapy and depression: are we overlooking an important therapeutic alternative?: Hormonal therapy and depression
37
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice
4
Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production.
7
Can nanotechnology potentiate photodynamic therapy?
37
Prostate segmentation in HIFU therapy.
13
Issues in image-guided therapy.
6
From Embryo Research to Therapy
13
Photodynamic therapy of cancer: an update.
32
Gene Therapy for ALS—A Perspective
22
The Future of Lipid-Lowering Therapy
17
Personalising metformin therapy: a clinician's perspective
5
Radiopharmaceutical dosimetry in targeted radionuclide therapy
251